News for hackers. Stuff that matters.
Re:Biohackers take aim at big pharma’s stranglehold on insulin by refurb on Monday June 28, 2021 @08:33PM (#27670175)
No, it is the question because countries with public health systems often don’t pay for the latest generation of drugs, since they don’t feel the extra cost is worth the benefit.
Re:Biohackers take aim at big pharma’s stranglehold on insulin by ravitation on Tuesday June 29, 2021 @04:55PM (#27681604)
My comment answered that "countries with public health systems" actually do "pay" for the "latest generation insulin" (i.e. the price for the "latest generation insulin" is still a tiny fraction the cost in the United States).

Just repeating the question, when I gave you the answer, isn't very productive.

Re:Biohackers take aim at big pharma’s stranglehold on insulin by jjmarinho on Monday June 28, 2021 @10:18PM (#27670947)
It's still the wrong question to ask.

We should ask what are the outcomes that these systems produce, not how new the drugs are.

A cutting-edge healthcare system plagued by inequality and extreme costs can produce worse results than a more efficient healthcare system which is not as high-tech.

Re:Biohackers take aim at big pharma’s stranglehold on insulin by refurb on Tuesday June 29, 2021 @12:03AM (#27671629)
Well all the diabetics in this discussion are claiming they can’t do without the latest generation insulin.

But yes, I agree. Sometimes the juice isn’t worth the squeeze.